Hyperargininemia: Clinical Trials

3 trials for Hyperargininemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Recruiting 1
Phase 12Completed 1, Recruiting 1

Follow Hyperargininemia: new trials by email Literature Review of Hyperargininemia trials Research Report on Hyperargininemia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1/2 Study of KRRO-121 in Healthy Volunteers and Patients With UCD
KRRO-121, Placebo - Urea Cycle Disorders, Inborn, Urea Cycle Disorders
Phase 1 / Phase 2RecruitingKorro Bio, Inc.302026-09-282026-10-08
A Study of AEB1102 (Pegzilarginase) in Patients With Arginase 1 Deficiency
AEB1102 - Arginase I Deficiency, Hyperargininemia
Phase 2CompletedImmedica Pharma AB142017-12-072026-09-24
A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency
AEB1102 - Arginase I Deficiency, Hyperargininemia
Phase 1 / Phase 2CompletedAeglea Biotherapeutics162016-06-012019-06-12

Narrower conditions

Adult-onset citrullinemia type 2 (1)  ·  Argininosuccinic Aciduria (1)  ·  N-acetyl glutamate synthetase deficiency (1)  ·  Ornithine Carbamoyltransferase Deficiency Disease (1)  ·  Urea Cycle Disorders, Inborn (1)

Broader conditions

Amino Acid Metabolism, Inborn Errors (3)  ·  Brain Diseases (3)  ·  Brain Diseases, Metabolic (3)  ·  Brain Diseases, Metabolic, Inborn (3)  ·  Central Nervous System Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Metabolic Diseases (3)  ·  Metabolism, Inborn Errors (3)  ·  Nervous System Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Urea Cycle Disorders, Inborn (2)  ·  Genetic Diseases, X-Linked (1)

Sponsors

Aeglea Biotherapeutics (1)  ·  Immedica Pharma AB (1)  ·  Korro Bio, Inc. (1)

Countries

Canada (2)  ·  Portugal (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Australia (1)

Top investigators

Josie Gayton (1)  ·  Mattias Rudebeck, PhD MSc BMedSc (1)

Results publications

PMID 33325055